LA JOLLA PHARMACEUTICAL CO (LJPC)

Recent Material Events for LA JOLLA PHARMACEUTICAL CO
Date Description
Jan 17, 2013 On January 17, 2013, La Jolla Pharmaceutical Company (the "Company") issued a press release. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.
Jan 14, 2013 On January 14, 2013, La Jolla Pharmaceutical Company (the "Company") issued a press release. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.
Jan 14, 2013 On January 8, 2013, the Board of Directors of La Jolla Pharmaceutical Company (the "Company"), approved the engagement of Squar, Milner, Peterson, Miranda & Williamson, LLP ("Squar Milner") as the Company's independent registered public accountant to
Dec 17, 2012 On December 17, 2012, La Jolla Pharmaceutical Company (the "Company") issued a press release. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.
Dec 10, 2012 On December 7, 2012, La Jolla Pharmaceutical Company, a California corporation (the "Company") entered into a Consent and Waiver Agreement (the "Agreement") with certain holders of the Company's preferred stock, as set forth in the Agreement (the "Ho
Dec 06, 2012 On December 5, 2012, La Jolla Pharmaceutical Company (the "Company") issued a press release. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.
Aug 03, 2012 On July 31, 2012, La Jolla Pharmaceutical Company (the "Company") issued a press release. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.
Jul 13, 2012 99.1 Presentation used in connection with RetailInvestorConferences.com Live Webcast on July 12, 2012. SIGNATURES
Jun 20, 2012 At the Annual Meeting of Stockholders of La Jolla Pharmaceutical Company, a Delaware corporation (“ LJPC Delaware ”) on May 22, 2012, LJPC Delaware’s stockholders, upon the recommendation of its Board of Directors, approved a proposal
May 31, 2012 Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.